An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 ΔGAG knock-in mice.
about
Enhanced hippocampal long-term potentiation and fear memory in Btbd9 mutant miceStriatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystoniaCholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA.In vivo imaging reveals impaired connectivity across cortical and subcortical networks in a mouse model of DYT1 dystonia.Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia.Prenatal ethanol exposure alters synaptic plasticity in the dorsolateral striatum of rat offspring via changing the reactivity of dopamine receptor.Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice.Pre-synaptic release deficits in a DYT1 dystonia mouse model.Minimal Change in the cytoplasmic calcium dynamics in striatal GABAergic neurons of a DYT1 dystonia knock-in mouse model.Behavioral and electrophysiological characterization of Dyt1 heterozygous knockout mice.Mutations in HPCA cause autosomal-recessive primary isolated dystoniaImproved motor performance in Dyt1 ΔGAG heterozygous knock-in mice by cerebellar Purkinje-cell specific Dyt1 conditional knocking-outFunctional activity of the sensorimotor cortex and cerebellum relates to cervical dystonia symptoms.Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia.Subtle microstructural changes of the striatum in a DYT1 knock-in mouse model of dystonia.Engineering animal models of dystoniaDystonia as a network disorder: what is the role of the cerebellum?Striatal cholinergic interneurons in isolated generalized dystonia-rationale and perspectives for stem cell-derived cellular models.Probing striatal microcircuitry to understand the functional role of cholinergic interneurons.Hyperkinetic disorders and loss of synaptic downscaling.Mouse model of rare TOR1A variant found in sporadic focal dystonia impairs domains affected in DYT1 dystonia patients and animal modelsElectromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia.Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors.Enhanced mu opioid receptor-dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia.The Anatomical Basis for Dystonia: The Motor Network Model.Forebrain knock-out of torsinA reduces striatal free-water and impairs whole-brain functional connectivity in a symptomatic mouse model of DYT1 dystonia.Miniature release events of glutamate from hippocampal neurons are influenced by the dystonia-associated protein torsinA.Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum.
P2860
Q21090923-5491FA06-0015-436D-84B4-685AA385C386Q28648007-D052E1AF-1661-4659-B6E2-B12F1C6E25D3Q31061478-DEA218C9-5129-44CE-B59E-C389FFD0C4D2Q31114074-C4E55B17-CBD6-470F-BF13-6055A967219AQ33863502-9E4809F7-7136-4BCC-847C-C66847CAF431Q34206423-551DD8BD-D587-4B5B-8294-890AFB75F6D6Q34390849-C7511DC8-F6B1-41D9-91AB-108A00372490Q34866730-B8BECAAE-A341-4EF9-894F-683A73899D4FQ34965241-38731ABE-B963-478C-AF45-49A82770F668Q35049257-CB543208-330D-4941-9B4E-9BF84104C844Q35208664-AFC43EEF-870E-41E7-947E-2D2746B2A353Q35266327-A174D006-37CF-4A3E-B845-264FF6E23CC2Q35878028-217DC748-04FE-448C-896F-F97A09D91818Q36395669-DDAC0F08-6B75-4221-A840-00A1875DABA8Q36400471-EBB8085F-19BF-45D8-9E9E-D11E42906928Q36774120-55BA2693-9054-4494-865A-7737F235B497Q37239952-DC4A42B1-07FF-4D8A-BDD7-F99F8BBCB2DDQ37592345-49AB7C0C-8B03-4FAA-AE12-78889CD451B7Q38239643-7A0FA68C-1019-4561-BC63-83821BA0DDFFQ38557880-2F84517E-D9FC-4947-B028-4F1E645BC44FQ38847727-869E9C6E-4E1A-4EAE-B6E3-3E1B7961A520Q41890579-75BA44EA-0056-453A-AB15-19E2989CD8B7Q42755733-CEB90595-BDCD-4606-8AE6-80AB0D94931DQ42971243-3E313EF6-B5C1-472E-8B0F-5C106FCCEA35Q44351170-E2A8A3CA-D5C3-461C-8700-AE0B3B7CACCDQ46481280-3CD46A3D-CC98-47D8-9A57-509748995E2DQ47837712-370FF767-FD79-42B7-9CCB-5B1A2D85B54FQ48161931-3A577C65-7BAB-406F-99C5-92B7EDF85B8BQ50420863-D02D3122-1744-4E1F-B1B7-3EA1842CB5FE
P2860
An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 ΔGAG knock-in mice.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
An anticholinergic reverses mo ...... ts in Dyt1 ΔGAG knock-in mice.
@ast
An anticholinergic reverses mo ...... ts in Dyt1 ΔGAG knock-in mice.
@en
type
label
An anticholinergic reverses mo ...... ts in Dyt1 ΔGAG knock-in mice.
@ast
An anticholinergic reverses mo ...... ts in Dyt1 ΔGAG knock-in mice.
@en
prefLabel
An anticholinergic reverses mo ...... ts in Dyt1 ΔGAG knock-in mice.
@ast
An anticholinergic reverses mo ...... ts in Dyt1 ΔGAG knock-in mice.
@en
P2093
P2860
P1476
An anticholinergic reverses mo ...... ts in Dyt1 ΔGAG knock-in mice.
@en
P2093
Chad C Cheetham
David M Lovinger
Fumiaki Yokoi
Mai T Dang
P2860
P304
P356
10.1016/J.BBR.2011.10.002
P407
P50
P577
2011-10-08T00:00:00Z